Event / Seminar

On November 30, 2018 Sonderhoff & Einsel’s Kengo Sakai Gave a Presentation at the EU-Japan Centre’s Event titled, “Recent Developments in EU and Japanese IP and Privacy Law “

On November 30, 2017, the EU-Japan Centre for Industrial Cooperation held an event at the Delegation of the European Union with regard to recent developments in EU and Japanese IP and privacy law.

 

The event offered an update as to how the European Unitary Patent system and the General Data Protection Regulations (GDPR) were expected to be implemented during the first half of 2019, and the second half of the event highlighted key court decisions from the EU and Japan on important intellectual property-related issues.

Sonderhoff & Einsel’s Kengo Sakai gave a well-received presentation titled, “Roundup of Recent Important IP-related Decisions in Japan” and his presentation focused on the IP High Court’s decision on the “Pyrimidine Derivative” Grand Panel Case and later participated in a panel discussion where there was a lively Q&A session among the speakers and the audience on this decision, IoT, and AI.

Continue Reading

On November 30, 2018, S&E and the EU-Japan Center for Industrial Cooperation Will Conduct a Seminar titled, “Recent Developments in EU and Japanese IP and Privacy Law.”

On November 30, 2017, S&E and the EU-Japan Center for Industrial Cooperation will conduct a seminar titled, “Recent Developments in EU and Japanese IP and Privacy Law” at the Delegation of the European Union. The details are as follows:

 

Date & Time: Friday, 30 November 2018, 14:00 – 19:00

(Registration at 13:30)

Venue: Delegation of the European Union to Japan (Tokyo)

Europa House, 4-6-28 Minami-Azabu, Minato-ku Tokyo 106-0047

Language: English/Japanese (simultaneous translation)

Fee: Free (pre-registration required)

Registration: via the EU-Japan Centre for Industrial Cooperation

Continue Reading

On August 30th, 2018 an event entitled “From the Ground Up: The Latest IP Information Related to Pharmaceutical Patents such as the China/Taiwan Patent Linkage System”

Sonderhoff & Einsel’s patent attorneys, Xiaofen Wu , Hiroshi Morita, and attorney-at-law, Ayuko Nemoto, gave a seminar on IP in China and Taiwan, which was held by Johokiko Co., Ltd. Currently, legal systems regarding the management of pharmaceuticals are taking shape in China and Taiwan and patent strategies for pharmaceuticals are playing an important role in companies’ business plans. In particular, the obtainment and exercise of patent rights heavily influence the profitability of these companies, and it has become crucially important to have a thorough understanding of such related matters.

 

Against this background, the seminar focused on the rapidly developing situation in China and Taiwan and the latest IP information related to pharmaceutical patents, such as the recent trends in the Chinese legal system and changes to the organization of the State Council (of the PRC), the China/Taiwan Patent Linkage System, generic drug development/filing and their relationship to patent rights, actual examples of patent management related to petitions for the filing of generic drugs made by Chinese firms, patent right infringement litigation in the Chinese pharmaceutical Industry and the Taiwan Pharmaceutical Patent Linkage System were discussed. In addition, Ms. Wu, Mr. Morita, and Ms. Nemoto introduced examples of recent decisions by the Supreme Court of the PRC as they relate to patent requirements for pharmaceutical patents and the interpretation of rights, and also explained certain points to keep in mind regarding the conduct of related business.

Continue Reading

On July 24, 2018, S&E sponsored an US IP seminar on the recent trends in the US Supreme Court’s and Court of Appeals for the Federal Circuit’s decisions, and their impact on the patent practices of Japanese corporations.

On July 24, 2018, S&E sponsored a US IP seminar on the recent trends in the US Supreme Court’s and Court of Appeals for the Federal Circuit’s decisions and their impact on the patent practices of Japanese corporations. The speaker was Professor Toshiko Takenaka who, while teaching at prominent universities such as Keio University Law School and Washington University School of Law, is involved in the acquisition and exercise of patent rights at Seed IP Law Group in Seattle. At the seminar, Ms. Takenaka explained the recent trends in US patent decisions related to the patentability, technical scope and exercise of rights for software development inventions, gene therapy, etc., and compared these trends with the practices in the EU and Japan.  She also touched on how these trends in court decisions shape prosecution as well as the details to keep in mind when drafting claims and specifications.

Continue Reading

On August 30, 2018: S&E will give a presentation on intellectual property in China and Taiwan — Basics regarding the patent linkage system and other pharmaceutical-related topics as well as the latest IP information –.

Xiaofen Wu (Patent Attorney) and Ayuko Nemoto (Attorney at Law) from Sonderhoff and Einsel will give a presentation at this seminar, which is being hosted by Johokiko Co., Ltd.. The topics to be covered at the seminar range from the essential basics on the patent linkage system related to pharmaceutical patents to the latest information on intellectual property.

 

Legal regulations concerning pharmaceuticals management in China and Taiwan are currently developing, and an understanding of these regulations is crucial. In addition, patent strategies for pharmaceuticals are becoming an important part of corporate management planning. Obtainment of patent rights and rights enforcement are particularly critical deciding factors in the profitability of pharmaceuticals.

 

This seminar will focus on rapidly developing China and Taiwan and explain the latest information on topics such as regulation trends in intellectual property — e.g., patent linkage systems and applications for approval of pharmaceuticals. Recent judicial decisions from the Supreme People’s Court (China) regarding the patentability of pharmaceutical patents and interpretation of rights as well as points to keep in mind during the practice thereof will also be covered.

Date: Thursday, 30 August 2018

Time: Seminar 13:30 – 16:30

Venue: Shinjuku Bunka Center, 4F, Meeting room No.2 (Japanese only)

6-14-1 Shinjuku, Shinjuku-ku, Tokyo 160-0022

 

Please click here for information on registration and more details regarding this seminar. (Japanese only)

Continue Reading

ON APRIL 25, 2018, S&E SPONSORED AN IP SEMINAR ON PATENT AND TRADEMARK PROSECUTION AND LITIGATION UNDER THAILAND LAW.

On April 25, 2018 Sonderhoff & Einsel Law and Patent Office sponsored a seminar in Tokyo for Domnern Somgiat & Boonma Law Office Ltd. from Thailand regarding the prosecution and enforcement of IP rights in Thailand. DS&B presented on the recent and planned revisions to Thai IP-related laws and provided concrete examples of IP enforcement in Thailand.  As the seminar was conducted in English, Sonderhoff & Einsel provided translation and interpretation services for DS&B.

Continue Reading

On April 20, 2018, FELIX EINSEL GAVE A PRESENTATION AT THE ANNUAL CONFERENCE FOR THE INSTITUTE OF PATENT AND TRADEMARK ATTORNEYS OF AUSTRALIA

On April 20, 2018 Felix Einsel gave a presentation in Melbourne, Australia, at the Annual Conference for IPTA (The Institute of Patent and Trademark Attorneys of Australia). In the business session titled “Taking Adverse Examination Decisions on Appeal, and other Advanced Patent Office Proceedings in Korea, Thailand and Japan”, he spoke about the Appeal against the Decision of Refusal & Opposition/Invalidation Trial in Japan.

Continue Reading

On December 8, 2017 in Tokyo and on December 13, 2017 in Osaka: S&E Gave a Presentation at the WE21 Study Group Held By the Japan Intellectual Property Association (JIPA).

On December 8, 2017, Felix Einsel gave a presentation over 6 hours on the utilization and practice of intellectual property in the EU at the WE21 Study Group held by the Japan Intellectual Property Association (JIPA). He explained the current developments in intellectual property in the EU, in particular the chances of implementation of the unitary patent and unified patent court, latest EU regulations and directives, judgments by the Court of Justice of the European Union and based on the strong tendency that Japanese corporations are shifting their patent applications from the EPO to the German Patent Office, he talked about patent/utility model prosecution and enforcement at the German Patent Office and Courts. This year, 137 participants joined the seminar in Tokyo and 28 participants took part in the seminar in Osaka. The same seminar in an updated version is also planned for the next year.

Continue Reading